ICTRP Search Portal

Main

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.

Register:	ClinicalTrials.gov
Last refreshed on:	19 February 2015
Main ID:	NCT00596115
Date of registration:	05/01/2008
Prospective Registration:	No
Primary sponsor:	Bennett, James P., Jr., M.D., Ph.D.
Public title:	Treating Amyotrophic Lateral Sclerosis (ALS) With R(+) Pramipexole Dihydrochloride Monohydrate at 60 mg/Day
Scientific title:	Open Label Extension for Treating ALS With R(+) Pramipexole at 60 Milligrams Per Day
Date of first enrolment:	October 2005
Target sample size:
Recruitment status:	Temporarily not available
URL:	http://clinicaltrials.gov/show/NCT00596115
Study type:	Expanded Access
Study design:	N/A
Phase:	N/A

Countries of recruitment

Contacts

Key inclusion & exclusion criteria

Inclusion Criteria:

- Definite diagnosis of ALS

Exclusion Criteria:

- No prior participation in R(+)PPX clinical studies

Age minimum: 30 Years
Age maximum: 80 Years
Gender: Both

Health Condition(s) or Problem(s) studied

Amyotrophic Lateral Sclerosis

Intervention(s)

Drug: R(+) pramipexole dihydrochloride monohydrate

Primary Outcome(s)

Secondary Outcome(s)

Secondary ID(s)

12316

Source(s) of Monetary Support

Please refer to primary and secondary sponsors

Secondary Sponsor(s)

University of Nebraska

University of Pittsburgh

Ethics review

Results

Results available:
Date Posted:
Date Completed:
URL:

Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.